VYNE

VYNE Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

0.00%

p/e

p/bv

DIVIDEND YIELD

VYNE price

VYNE Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VYNE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VYNE

Valuation

P/E

Sector -2.32

Industry -7.08

P/BV

Sector 2.20

Industry 1.99

P/Revenue (PSR)

Sector 1.98

Industry 2.99

EV/EBITDA

Sector -17.91

Industry -26.42

EV/EBIT

Sector -32.00

Industry -30.44

P/EBITDA

Sector 0.65

Industry -3.76

P/EBIT

Sector -2.86

Industry -6.18

P/Total Assets

Sector 1.21

Industry 1.34

P/Net Current Assets

Sector -10.77

Industry -7.20

P/Working Capital

Sector -4.09

Industry -3.05

EPS

Sector -0.86

Industry -1.29

BVPS

Sector 3.90

Industry 2.12

Efficiency

Gross Margin

Sector 44.00%

Industry 44.97%

EBITDA Margin

Sector -331.60%

Industry -17,446,220.00%

EBIT Margin

Sector -188.01%

Industry -17,386,077.49%

Operating Margin

Sector -24.42%

Industry -32.79%

Net Profit Margins

Sector -28.72%

Industry -34.98%

Asset Turnover

Sector 0.12

Industry 0.06

Profitability

ROE

0.00%

Sector -33.72%

Industry -48.74%

ROA

Sector -29.12%

Industry -52.31%

ROIC

0.00%

Sector -416.63%

Industry -444.04%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.84

Industry 2.21

Net Debt / EBITDA

Sector 0.20

Industry 1.94

Net Debt / EBIT

Sector -1.28

Industry 1.90

Net Debt / Equity

Sector -0.37

Industry -0.72

Gross Debt / Equity

Sector 0.16

Industry 0.03

Equity/Assets

Sector 0.42

Industry 0.46

Liabilities/Assets

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals VYNE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VYNE VYNE Therapeutics Inc.	$0.00	-100.00%	0.00%	-	-	0.00%	0.00%
LLY Eli Lilly and Compay	$1,188.21	75.10%	0.55%	39.20	30.91	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$399.79	-17.12%	0.00%	42.46	7.28	17.15%	28.45%
SNY Sanofi	$43.70	-6.81%	4.06%	7.07	1.30	18.43%	13.81%
NVS Novartis AG	$151.17	27.15%	1.99%	23.30	7.09	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$593.60	22.98%	0.31%	31.14	4.11	13.19%	15.04%
ABT Abbott Laboratories	$111.78	-11.16%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.82	2.03%	3.31%	22.98	2.20	9.59%	13.20%
GSK GlaxoSmithKline PLC	$49.23	31.57%	3.34%	16.28	4.60	28.24%	14.54%
CVS CVS Health Corporation	$97.41	52.48%	2.79%	24.95	1.53	6.12%	1.18%
BSX Boston Scientific Corp.	$52.52	-48.77%	0.00%	17.89	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$88.25	-33.17%	0.00%	18.66	5.46	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$552.82	-16.73%	0.00%	40.91	28.91	70.67%	25.03%
RMD ResMed Inc.	$225.48	-20.77%	1.15%	19.82	4.58	23.13%	26.94%
DHR Danaher Corporation	$203.38	-2.54%	0.71%	35.57	2.71	7.61%	15.95%
HCA HCA Healthcare Inc.	$406.18	4.71%	0.73%	13.27	-28.28	-213.15%	8.77%
SYK Stryker Corp.	$340.48	-9.00%	1.03%	34.67	5.39	15.55%	14.43%
COHR Coherent Inc.	$325.76	185.73%	0.00%	157.51	6.70	4.26%	7.10%
PHG Koninklijke Philips NV	$27.36	4.21%	3.80%	19.68	1.93	9.80%	6.30%
INMD InMode Ltd.	$15.17	3.52%	0.00%	11.60	1.43	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VYNE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/21/2026	07/23/2026	19.00000000
Dividends	07/23/2026	07/23/2026	20.10000000
Dividends	07/23/2026	07/23/2026	20.10000000
Dividends	07/23/2026	07/23/2026	20.10000000

ABOUT VYNE Therapeutics

VYNE Therapeutics Inc.

Average Investor10 user rating

4.0 (5 people)

United States

15 years

Founded: 2011

2018

Time since IPO - 8 years

40

Employees

VYNE Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-.

The company employs approximately 40 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, VYNE Therapeutics Inc. reported $- in revenue, generating net income of $-.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker VYNE.

Market cap

Net worth

Assets

Total Shares Outstanding

Average Daily Trading Volume

Sector

Health

Industry

Pharmaceutical Products

VYNE

VYNE revenue and profits

Financial Results VYNE

DRAG THE FRAME TO SEE MORE DATA

VYNE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.41 46,48% (12M)

P/E

24.95

2.79%

ROE

6.12%

P/BV

1.53

CI - Cigna

$281.76 --2,46% (12M)

P/E

10.74

2.21%

ROE

16.04%

P/BV

1.72

CNC - Centene

$66.90 134,82% (12M)

P/E

-6.36

0.00%

ROE

-22.51%

P/BV

1.43

HUM - Humana

$385.88 36,69% (12M)

P/E

35.81

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$43.70 --8,73% (12M)

P/E

7.07

4.06%

ROE

18.43%

P/BV

1.30

LLY - Eli Lilly

$1,188.21 71,69% (12M)

P/E

39.20

0.55%

ROE

78.84%

P/BV

30.91

HCA - HCA Healthcare

$406.18 3,30% (12M)

P/E

13.27

0.73%

ROE

-213.15%

P/BV

-28.28

NVS - Novartis

$151.17 24,07% (12M)

P/E

23.30

1.99%

ROE

30.41%

P/BV

7.09